GT Biopharma, Inc.

GTBP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q/A Mar 6, 2026 10-Q/A
10-K Mar 2, 2026 10-K
8-K Mar 2, 2026 8-K
EFFECT Jan 30, 2026
424B3 Jan 30, 2026 424B3
CORRESP Jan 28, 2026
UPLOAD Jan 27, 2026
S-1 Jan 21, 2026 S-1
424B3 Jan 8, 2026 424B3
EFFECT Dec 2, 2025
424B3 Dec 2, 2025 424B3
CORRESP Dec 2, 2025
8-K Nov 26, 2025 8-K
10-Q Nov 14, 2025 10-Q
8-K Nov 14, 2025 8-K
S-1 Oct 24, 2025 S-1
8-K Sep 26, 2025 8-K
8-K Sep 23, 2025 8-K
4 Sep 8, 2025
4 Sep 8, 2025
4 Sep 8, 2025
4 Sep 8, 2025
4 Sep 8, 2025
8-K Aug 29, 2025 8-K
10-Q Aug 14, 2025 10-Q
← Newer Page 2 of 33 · 811 filings Older →